Altaris Reports the Acquisition of Sharecare
Shots:
- Altaris has signed a definitive agreement to acquire Sharecare for $1.43 per share in cash, making it an aggregate of ~$540M
- Sharecare will operate as a private firm upon completion of the transaction (anticipated during H2’24) depending on customary closing conditions, such as Sharecare stockholder approval & required regulatory approvals
- Sharecare’s portfolio consists data-driven virtual health platform with a goal of improving health and well-being of providers, employers, health plans, government organizations, and communities
Ref: Altaris | Image: Altaris
Related News:- ARCA Biopharma Signs a Definitive Merger Agreement with Oruka Therapeutics to Develop Biologics for Chronic Skin Diseases
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
